Biosenta to Field-Test Antimicrobial Nanoparticles with Livespace Homes in Alberta Multi-Unit Build
Ontario and Calgary, Alberta--(Newsfile Corp. - December 11, 2025) - Biosenta Inc. (CSE: ZRO) ("Biosenta") On December 8, 2025 Biosenta has entered into a Field Test and Research Agreement with Livespace Homes to evaluate the real-world performance of Biosenta's proprietary antimicrobial nanoparticle technology in a residential construction environment. Under the agreement, the nanoparticles will be incorporated into building materials and/or coatings used in two (2) of the four (4) units of...
2025-12-11 2:21 PM EST
Former Canadian Coatings Association President & CEO Gary LeRoux joins Biosenta's Advisory Board
Ontario and Calgary, Alberta--(Newsfile Corp. - October 1, 2025) - Biosenta Inc. (CSE: ZRO) ("Biosenta") today announced that Gary LeRoux, past President and CEO of the Canadian Coatings Association (CCA), has joined the company's advisory board.Gary LeRoux, CFA, joins Biosenta Inc. as strategic advisor. (CNW Group/Biosenta Inc.)To view an en
2025-10-01 8:00 AM EDT
Veteran Finance Executive Tim Gillespie, CFA, Joins Biosenta as Strategic Advisor
Ontario and Calgary, Alberta--(Newsfile Corp. - July 21, 2025) - Biosenta Inc. (CSE: ZRO) ("Biosenta") today announced that Tim Gillespie, CFA has joined the company as a strategic advisor. In this role, Mr. Gillespie will counsel Biosenta's executive team and board on financing, risk management and go-to-market strategy as the company scales production and commercialization of its Tri-Filler™ antimicrobial technology.
2025-07-21 5:00 PM EDT
Biosenta's Tri-Filler(TM) Nanoparticles Achieve 100% Killing of Pathogens at Industry-Low Dose in Peer-Reviewed Studies
Ontario and Calgary, Alberta--(Newsfile Corp. - June 11, 2025) - Biosenta Inc. (CSE: ZRO) ("Biosenta") today announced that two independent, peer-reviewed studies conducted at the University of Calgary confirmed that its proprietary Tri-Filler™ core-shell calcium hydroxide-calcium carbonate (CSCC™) nanoparticles achieved complete (100 %) bactericidal activity against multiple World Health Organization (WHO) priority pathogens and keep working far longer than conventional...
2025-06-11 1:15 PM EDT
Biosenta Inc. Achieves Major Breakthroughs in Bench Scale Production and Innovative Input Viability
Ontario and Calgary, Alberta--(Newsfile Corp. - June 10, 2024) - Biosenta Inc. (CSE: ZRO) ("Biosenta" or the "Company"), a leader in developing eco-friendly antimicrobial compounds, is pleased to announce significant advancements at its state-of-the-art bench scale production facility, which have exceeded all expectations. These breakthroughs not only demonstrate the capability of the bench scale facility but also mark the beginning of preparations for a commercial scale production...
2024-06-10 4:30 PM EDT
Biosenta Inc. Announces Licensing Agreement with Lightweight Concrete Solutions
Ontario and Calgary, Alberta--(Newsfile Corp. - May 8, 2024) - Biosenta Inc. (CSE: ZRO) ("Biosenta" or the "Company") is pleased to announce a strategic milestone, having entered into a license agreement (the "License Agreement") with 2581776 Ontario Inc. (dba Lightweight Concrete Solutions) ("Lightweight Concrete Solutions") pursuant to which Biosenta granted to Lightweight Concrete Solutions a license to use Biosenta's Tri-Filler® technology in connection with certain specialty concrete...
2024-05-08 4:53 PM EDT
Biosenta Closes Private Placement Financing
Toronto, Ontario--(Newsfile Corp. - April 26, 2024) - Biosenta Inc. (CSE: ZRO) (the "Company" or "Biosenta"), is pleased to announce that it has closed its private placement for gross proceeds of $600,000 (the "Offering"), as previously announced on April 19, 2024. Biosenta issued 1,500,000 units (each, a "Unit") under the Offering at a price of $0.40 per Unit, with each Unit consisting of one common share in the capital of the Company (each, a "Common Share") and one half of...
2024-04-26 7:20 PM EDT
Biosenta Announces Private Placement Financing
Toronto, Ontario--(Newsfile Corp. - April 19, 2024) - Biosenta Inc. (CSE: ZRO) ("Biosenta" or the "Company") is pleased to announce a non-brokered private placement financing (the "Offering") of up 1,500,000 units of the Company (the "Units") at a price of $0.40 per Unit, for aggregate gross proceeds of up to $600,000.Each Unit will consist of one common share in the capital of the Company and one half of one common share purchase warrant (each whole warrant, a "Warrant"). Each Warrant...
2024-04-19 5:59 PM EDT
Biosenta Announces Successful Launch of Bench Scale Production Plant and Exceeding Expectations of Tri-Filler(TM) Particle Encapsulation Technology
Ontario and Calgary, Alberta--(Newsfile Corp. - March 27, 2024) - Biosenta Inc. (CSE: ZRO) ("Biosenta" or the "Company") is pleased to announce a significant milestone in its technological and operational advancements with the successful construction and operation of a bench scale production plant. The results from this production not only surpassed our expectations, but also showcased that our patented Tri-Filler™ antimicrobial technology is ready for accelerated development and scaling...
2024-03-27 12:25 PM EDT
Amarvir Gill Holdings in Biosenta Inc.
Toronto, Ontario--(Newsfile Corp. - February 22, 2024) - Amarvir Gill (the "Acquiror"), the President, Chief Executive Officer and a Director of Biosenta Inc. ("Biosenta") listed on the Canadian Securities Exchange (CSE: ZRO) announces that he acquired 1,250,000 common shares (the "Shares") and 625,000 warrants to purchase common shares (the "Warrants") pursuant to a debt settlement transaction whereby Biosenta issued the Shares 1,250,000 and 625,000 Warrants to settle $500,000 in debt owed...
2024-02-22 1:20 PM EST
Biosenta Announces Closing of Previously Announced Transaction
Toronto, Ontario--(Newsfile Corp. - February 21, 2024) - Biosenta Inc. (CSE: ZRO) (the "Company" or "Biosenta"), is pleased to announce that it has entered into debt settlement agreements with certain creditors, pursuant to which the Company agreed to settle an aggregate amount of $784,919 in outstanding debt (the "Transaction") in exchange for the issuance of 1,962,297 units at a price of $0.40 per unit (each, a "Unit"), in accordance with the policies of the Canadian Securities Exchange....
2024-02-21 4:28 PM EST
Biosenta Announces Debt Settlement
Toronto, Ontario--(Newsfile Corp. - January 31, 2024) - Biosenta Inc. (CSE: ZRO) ("Biosenta" or the "Company"), announces that it intends to enter into debt settlement agreements (the "Agreements") with certain creditors (together, the "Creditors"), pursuant to which the Company will agree to settle an aggregate amount of $784,919 in outstanding debt (the "Debt Settlement") in exchange for the issuance of 1,962,297 units at a price of $0.40 per unit (each, a "Unit"), in accordance with the...
2024-01-31 3:29 PM EST
Biosenta Announces Engagement of Oak Hill Financial Inc.
Toronto, Ontario--(Newsfile Corp. - January 11, 2024) - Biosenta Inc. (CSE: ZRO) ("Biosenta" or the "Company") announces that it has entered into an agreement with Oak Hill Financial Inc. ("Oak Hill") to provide business and capital markets advisory services to the Company and/or its affiliates and/or subsidiaries on a best efforts basis (the "Agreement"). Certain services to be provided by Oak Hill are anticipated to include "investor relations activities" under the policies of the Canadian...
2024-01-11 12:38 PM EST
Biosenta Closes Private Placement Financing
Toronto, Ontario--(Newsfile Corp. - December 27, 2023) - Biosenta Inc. (CSE: ZRO) (the "Company" or "Biosenta"), is pleased to announce that it has closed its private placement for gross proceeds of $500,000 (the "Offering"), as previously announced on December 15, 2023. Biosenta issued 1,250,000 units (each, a "Unit") under the Offering at a price of $0.40 per Unit, with each Unit consisting of one common share in the capital of the Company (each, a "Common Share") and one half of...
2023-12-27 3:27 PM EST
Biosenta Announces Private Placement Financing
Toronto, Ontario--(Newsfile Corp. - December 15, 2023) - Biosenta Inc. (CSE: ZRO) ("Biosenta" or the "Company") is pleased to announce a non-brokered private placement financing (the "Offering") of 1,250,000 units of the Company (the "Units"), for aggregate gross proceeds of $500,000.Each Unit will consist of one common share in the capital of the Company and one half of common share purchase warrant (each whole warrant, a "Warrant"). Each Warrant will entitle the holder thereof to acquire,...
2023-12-15 8:30 AM EST